FAE: Revenues up 15.5% to €454M, adjusted EBITDA +3%, net profit down 7.6% year-over-year
· Issued by Faes Farma, S.A.
Revenues grew 15.5% year-over-year to €454M, with strong performance in pharma, international, and animal nutrition segments. Adjusted EBITDA rose 3%, while net profit declined 7.6%. Strategic acquisitions and new product approvals supported growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
